Davis Polk advised the dealer manager on a cash tender offer by Bristol-Myers Squibb Company for any and all of its 5.875% notes due 2036, 6.125% notes due 2038 and 6.875% debentures due 2097.

Headquartered in New York City, BMS engages in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis.

The Davis Polk corporate team included partners Richard A. Drucker and Sophia Hudson and associates Hillary A. Coleman and Bria J.M. Cunningham. Partner Kathleen L. Ferrell and associate Jonathan Atkins provided tax advice. All members of the Davis Polk team are based in the New York office.

Copy link to share post